Pliant Therapeutics PLRX
NASDAQ PLRX
$0.79 -0.01 (-1.28%)
As of: Nov 10, 2026 · 2:14 PM EST

Pliant Therapeutics (PLRX) Receivables - Other (2019 - 2022)

Updated

Pliant Therapeutics' Receivables - Other came in at $4 million for Q4 2022, up 100.0% from $2 million a year earlier and unchanged from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) Receivables - Other (2019 - 2022) Analysis & Trends

Going back to Q4 2019, Pliant Therapeutics' Receivables - Other data covers 8 quarters.

  • Receivables - Other carries a three-year compound annual growth rate of -17.4% (FY2019 to FY2022).
  • Going back by year, Receivables - Other was $2 million in FY2021 (-78.5%), $9.3 million in FY2020 (+31.0%) and $7.1 million in FY2019.
  • The five-year range for quarterly Receivables - Other is $2 million (Q4 2021) to $9.3 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Pliant Therapeutics 50.15 Mn -711.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 4.00 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 4.00 Mn
Dec 31, 2021 2.00 Mn
Dec 31, 2020 9.30 Mn
Sep 30, 2020 7.10 Mn
Jun 30, 2020 3.60 Mn
Dec 31, 2019 7.10 Mn
API Access

Pliant Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=PLRX&period=max&api_key=YOUR_API_KEY